Beyond CPRA: Identifying Sensitized Kidney Candidates with Markedly Low Access to Deceased Donor Transplantation by Granular CPRA and Blood Type
OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 7 days from acceptance to publication (median values for papers published in this journal in 2020, 1-2 days of FREE language polishing time is also included in this period).
Donor Specific Antibody
Submission Deadline: July 30, 2021 (Open) Submit Now
Christophe Picard, MD, PhD, HDR
Biologiste médical, Directeur Biologie thérapie et Diagnostic, Responsable du laboratoire d’immunogénétique et d’histocompatibilié –Site Marseille-EFS-AM, Aix-Marseille University, UM 105, Marseille, France; HLA Immunogenetic Laboratory, Blood Bank, Marseille, France
Research Interests: Genotyping; transplantation; immunology; T lymphocytes; genetics; antibodies; clinical immunology; stem cell transplantation; donor specific antibody
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.